← Eichor
Condition: Mycophenolate Mofetil Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mycophenolate Mofetil

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens
Phase 2/Phase 3 · 56 location(s) · University Hospital, Angers · NCT02416388Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Live
Phase 4 · 18 location(s) · University Hospital, Limoges · NCT06354179Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versu
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06996119The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofet
Phase 1/Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT05436418The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Phase 2 · 19 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05538208Graves' Disease Remission Study: MycoMeth Combo
Phase 2/Phase 3 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06068179Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective
Phase 4 · 3 location(s) · Mayo Clinic · NCT06568549The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus
NA · 1 location(s) · The University of Hong Kong · NCT02954939Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung
Phase 3 · 1 location(s) · University Hospital, Tours · NCT06549231A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophospham
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06973668Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus
Phase 4 · 1 location(s) · Chinese SLE Treatment And Research Group · NCT05916781Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycopheno
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04702256Short-term Glucocorticoid Combined with MMF for IgG4-RD
NA · 1 location(s) · Wen Zhang · NCT06663618Cord Blood Transplant in Adults With Blood Cancers
Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT05884333VIBRANT: VIB4920 for Active Lupus Nephritis
Phase 2 · 17 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05201469Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch
Phase 4 · 1 location(s) · University Hospital, Antwerp · NCT06493526Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Phase 2 · 1 location(s) · University of Nebraska · NCT06799195The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patien
Phase 2 · 1 location(s) · Nanjing University School of Medicine · NCT07340463Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Phase 2 · 3 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05785065Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura
NA · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05951517A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil
Phase 3 · 30 location(s) · Incyte Corporation · NCT06615050The Mycophenolate Pregnancy Registry
Phase N/A · 1 location(s) · Genentech, Inc. · NCT01733082
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.